Subscribe to RSS
DOI: 10.1055/s-0041-110395
Touch Imprint Cytology and Stereotactically-Guided Core Needle Biopsy of Suspicious Breast Lesions: 15-Year Follow-up
Abrollzytologie und stereotaktische Stanzbiopsien auffälliger Befunde der Brust: 15-Jahres-Follow-upPublication History
received 02 September 2015
revised 27 November 2015
accepted 29 November 2015
Publication Date:
03 February 2016 (online)
Abstract
Introduction: Stereotactically-guided core needle biopsies (CNB) of breast tumours allow histological examination of the tumour without surgery. Touch imprint cytology (TIC) of CNB promises to be useful in providing same-day diagnosis for counselling purposes and for planning future surgery. Having addressed the issue of accuracy of immediate microscopic evaluation of TIC, we wanted to re-examine the usefulness of this procedure in light of the present health care climate of cost containment by incorporating the surgical 15-year follow-up data and outcome. Patients and Methods: From January until December 1996 we performed TIC in core needle biopsies of 173 breast tumours in 169 patients, consisting of 122 malignant and 51 benign tumours. Histology of core needle biopsies was proven by surgical histology in all malignant and in 5 benign tumours. Surgical breast biopsy was not performed in 46 patients with 46 benign lesions, as the histological result from the core needle biopsy and the result of the TIC were in agreement with the suspected diagnosis from the complementary breast diagnostics. A 15-year follow-up of these patients followed in 2013 and follow-up data was collected from 40 women. Results: In the 15-year follow-up of the 40 benign lesions primarily confirmed using CNB and TIC, a diagnostic sensitivity, specificity, positive and negative predictive value and accuracy of 100 % was found. Conclusion: TIC and stereotactically guided CNB showed excellent long-term follow-up in patients with benign breast lesions. The use of TIC to complement CNB can therefore provide immediate cytological diagnosis of breast lesions.
Zusammenfassung
Einleitung: Die stereotaktische Stanzbiopsie erlaubt eine histologische Untersuchung von Brusttumoren ohne chirurgischen Eingriff. Die gleichzeitige zytologische Beurteilung von Abrollpräparaten der Stanzzylinder hat den Vorteil, dass das Ergebnis noch am selben Tag vorliegt und für die Beratung und Planung zukünftiger Eingriffe herangezogen werden kann. Nach unserer Untersuchung der mikroskopischen Beurteilung der Abrollzytologie ging es nun darum, die Nützlichkeit dieses Verfahrens im Hinblick auf die aktuelle Debatte um die Kostendämpfung im Gesundheitswesen zu beurteilen. Daten aus dem 15-Jahres-Follow-up von Patientinnen wurden zur Beurteilung des Verfahrens eingesetzt. Patienten und Methoden: Zwischen Januar und Dezember 1996 wurden 173 stereotaktische Stanzbiopsien von Brusttumoren bei 169 Patientinnen durchgeführt. Die Stanzzylinder wurden zusätzlich zytologisch untersucht. Die Befundung ergab 122 bösartige und 51 gutartige Tumoren. Die Histologie der in der Stanzbiopsie entnommenen Proben wurde bei allen bösartigen und 5 der gutartigen Tumoren chirurgisch bestätigt. Es wurden keine chirurgischen Brustbiopsien bei 46 Patientinnen mit 46 gutartigen Tumoren durchgeführt, da der auf der Stanzbiopsie beruhende histologische Befund sowie das Ergebnis der Abrollzytologie mit der vermuteten Diagnose aus der komplementären Brustdiagnostik übereinstimmte. Das 15-Jahres-Follow-up erfolgte im Jahre 2013 mit der Auswertung der Follow-up-Daten von 40 Patientinnen. Ergebnisse: Beim 15-Jahres-Follow-up von 40 gutartigen Tumoren, die primär mittels stereotaktischer Stanzbiopsie und Abrollzytologie abgeklärt worden waren, betrugen die diagnostische Sensitivität, die Spezifizität, der positive und negative Vorhersagewert und die Genauigkeit jeweils 100 %. Schlussfolgerung: Sowohl die stereotaktische Stanzbiopsie als auch die Abrollzytologie zeigten bei Patientinnen mit gutartigen Brustveränderungen gute Langzeitergebnisse. Die Abrollzytologie könnte somit eine gute Ergänzung zur stereotaktischen Stanzbiopsie sein, wenn eine sofortige zytologische Diagnose von Brustveränderungen benötigt wird.
-
References
- 1 Berg WA, Gutierrez L, NessAiver MS et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004; 233: 830-849
- 2 Heywang-Koebrunner S, Bock K, Heindel W et al. Mammography Screening – as of 2013. Geburtsh Frauenheilk 2013; 73: 1007-1016
- 3 Bukhari MH, Akhtar ZM. Comparison of accuracy of diagnostic modalities for evaluation of breast cancer with review of literature. Diagn Cytopathol 2009; 37: 416-424
- 4 NHS Breast Screening Programme No. 50: Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening. June 2001,. Public Health, Gov. UK;
- 5 NHS Breast Screening Programme No. 58: Guidelines for pathology reporting in breast disease. January 2005. Public Health, Gov. UK;
- 6 Schulz-Wendtland R, Wenkel E, Imhoff K. Diagnostik von Brustdrüsenerkrankungen. Biopsiemethoden im Vergleich. GynäkolPrax 2004; 28: 607-625
- 7 Ariga R, Bloom K, Reddy VB et al. Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation. Am J Surg 2002; 184: 410-413
- 8 Boerner S, Fornage BD, Singletary E et al. Ultrasound-guided fine-needle aspiration (FNA) of nonpalpable breast lesions: a review of 1885 FNA cases using the National Cancer Institute-supported recommendations on the uniform approach to breast FNA. Cancer 1999; 87: 19-24
- 9 Pilgrim S, Ravichandran D. Fine needle aspiration cytology as an adjunct to core biopsy in the assessment of symptomatic breast carcinoma. Breast 2005; 14: 411-414
- 10 Kreienberg R, Albert US, Follmann M et al. Interdisciplinary GoR level III guidelines for the diagnosis, therapy and follow-up care of breast cancer. Short version – AWMF Registry No.: 032-045OL. Geburtsh Frauenheilk 2013; 73: 556-583
- 11 Cross MJ, Evans WP, Peters GN et al. Stereotactic breast biopsy as an alternative to open excisional biopsy. Ann Surg Oncol 1995; 2: 195-200
- 12 Dahlstrom JE, Jain S, Sutton T et al. Diagnostic accuracy of stereotactic core biopsy in a mammographic breast cancer screening programme. Histopathology 1996; 28: 421-427
- 13 Schulz-Wendtland R, Krämer S, Döinghaus K et al. [Interventional techniques in breast diagnosis: ultrasound controlled puncture biopsy]. Aktuelle Radiol 1997; 7: 30-34
- 14 Berner A, Davidson B, Sigstad E et al. Fine-needle aspiration cytology vs. core biopsy in the diagnosis of breast lesions. Diagn Cytopathol 2003; 29: 344-348
- 15 Dennison G, Anand R, Makar SH et al. A prospective study of the use of fine-needle aspiration cytology and core biopsy in the diagnosis of breast cancer. Breast J 2003; 9: 491-493
- 16 Hagedorn K, Krämer S, Mitze M et al. [Interventional methods in breast diagnosis. Histological vs. cytological evaluation of core cut biopsies of the breast]. Aktuelle Radiol 1998; 8: 278-282
- 17 Jacobs TW, Silverman JF, Schroeder B et al. Accuracy of touch imprint cytology of image-directed breast core needle biopsies. Acta Cytol 1999; 43: 169-174
- 18 Albert US, Duda V, Hadji P et al. Imprint cytology of core needle biopsy specimens of breast lesions. A rapid approach to detecting malignancies, with comparison of cytologic and histopathologic analyses of 173 cases. Acta Cytol 2000; 44: 57-62
- 19 Green RS, Mathew S. The contribution of cytologic imprints of stereotactically guided core needle biopsies of the breast in the management of patients with mammographic abnormalities. Breast J 2001; 7: 214-218
- 20 Newman MR, Frost FA, Sterrett GF et al. Diagnosis of breast microcalcifications: a comparison of stereotactic FNA and core imprint cytology as adjuncts to core biopsy. Pathology 2001; 33: 449-453
- 21 Masood S, Feng D, Tutuncuoglu O et al. Diagnostic value of imprint cytology during image-guided core biopsy in improving breast health care. Ann Clin Lab Sci 2011; 41: 8-13
- 22 NHS Breast Screening Programme No. 22: Guidelines for cytology procedures and reporting in breast screening. September 1993. Public Health, Gov. UK;
- 23 Dowlatshahi K, Gent HJ, Schmidt R et al. Nonpalpable breast tumors: diagnosis with stereotaxic localization and fine-needle aspiration. Radiology 1989; 170: 427-433
- 24 Killeen DM, Fraser F, Leinster SJ et al. The effect of stereotaxic fine-needle aspiration biopsy on the management of impalpable breast-lesions (Vol 3, Pg 173, 1994). Breast 1995; 4: 77
- 25 Kehl S, Mechler C, Menton S et al. Touch imprint cytology of core needle biopsy specimens for the breast and quick stain procedure for immediate diagnosis. Anticancer Res 2014; 34: 153-157
- 26 Qureshi NA, Beresford A, Sami S et al. Imprint cytology of needle core-biopsy specimens of breast lesions: is it a useful adjunt to rapid assessment breast clinics?. Breast 2007; 16: 81-85
- 27 Klevesath MB, Godwin RJ, Bannon R et al. Touch imprint cytology of core needle biopsy specimens: a useful method for immediate reporting of symptomatic breast lesions. Eur J Surg Oncol 2005; 31: 490-494
- 28 Sneige N, Tulbah A. Accuracy of cytologic diagnoses made from touch imprints of image-guided needle biopsy specimens of nonpalpable breast abnormalities. Diagn Cytopathol 2000; 23: 29-34